… using a single paclitaxel-eluting stent (TAXUS IV), 18 sirolimus-eluting stent in coronary
lesions (SIRIUS), 19 and randomized comparison of a sirolimus-eluting stent with a standard …

… Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle
cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with …

… We included in our analysis the results of randomized clinical trials that compared
sirolimus-eluting stents (Cypher or Cypher Select, Cordis) with bare-metal stents for management of …

… drug-eluting stents, such as SES, is undetermined. We therefore performed a randomized, …
coronary stent eluting zotarolimus versus sirolimus in patients with native coronary lesions. …

… Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial is a
prospective multicenter randomized open-label trial comparing EES with SES in Japan. The trial …

… Nine-month outcome of the SIRTAX trial: a randomized comparison of a sirolimus- with a
paclitaxel-eluting stent for coronary revascularization. Presented at: 2005 Scientific Session of …

Objectives : This study sought to compare the unrestricted use of everolimus-eluting stents (EES)
with sirolimus-eluting stents (SES) in patients undergoing percutaneous coronary …

… We identified 5 eligible randomized trials comparing EES with SES in 7370 patients. The
primary end point was major adverse cardiac events. Secondary end points were cardiac death…

… rate in our sirolimus group compared with that in the Biolimus-Eluting Stent With … A
randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary …

… study was to compare everolimus-eluting stents (EES) with sirolimus-eluting stents (SES)
in … A randomised comparison in a large cohort of unselected patients". Heart 2005; 91: 641. …